Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

被引:618
作者
Machado, Pedro [1 ,2 ]
Landewe, Robert [3 ]
Lie, Elisabeth [4 ]
Kvien, Tore K. [4 ]
Braun, Juergen [5 ]
Baker, Daniel [6 ]
van der Heijde, Desiree [1 ,4 ]
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
[2] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal
[3] Maastricht Univ, Med Ctr, Dept Rheumatol, Maastricht, Netherlands
[4] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[5] Rheumazentrum Ruhrgebiet, Dept Rheumatol, Herne, Germany
[6] Centocor Inc, Res & Dev, Malvern, PA 19355 USA
关键词
SHORT-TERM IMPROVEMENT; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; CRITERIA; AGENTS;
D O I
10.1136/ard.2010.138594
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess disease activity in ankylosing spondylitis (AS). It fulfils important aspects of truth, feasibility and discrimination. Criteria for disease activity states and improvement scores are important for use in clinical practice, observational studies and clinical trials and so far have not been developed for the ASDAS. Objective To determine clinically relevant cut-off values for disease activity states and improvement scores using the ASDAS. Methods For the selection of cut-offs data from the Norwegian disease modifying antirheumatic drug (NOR-DMARD) registry, a cohort of patients with AS starting conventional or biological DMARDs, were used. Receiver operating characteristic analysis against several external criteria was performed and several approaches to determine the optimal cut-offs used. The final choice was made on clinical and statistical grounds, after debate and voting by Assessment of SpondyloArthritis international Society members. Crossvalidation was performed in NOR-DMARD and in Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy, a database of patients with AS participating in a randomised placebo-controlled trial with a tumour necrosis factor blocker. Results Four disease activity states were chosen by consensus: inactive disease, moderate, high and very high disease activity. The three cut-offs selected to separate these states were: 1.3, 2.1 and 3.5 units. Selected cut-offs for improvement were: change >= 1.1 units for clinically important improvement and change >= 2.0 units for major improvement. Results of the crossvalidation strongly supported the cut-offs. Conclusions Cut-off values for disease activity states and improvement using the ASDAS have been developed. They proved to have external validity and a good performance compared to existing criteria.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 32 条
[1]   The importance of reporting disease activity states in rheumatoid arthritis clinical trials [J].
Aletaha, Daniel ;
Funovits, Julia ;
Smolen, Josef S. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (09) :2622-2631
[2]  
Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO
[3]  
2-F
[4]  
BAKKER C, 1993, J RHEUMATOL, V20, P1724
[5]   Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis [J].
Brandt, J ;
Listing, J ;
Sieper, J ;
Rudwaleit, M ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) :1438-1444
[6]   Ankylosing spondylitis [J].
Braun, Juergen ;
Sieper, Joachim .
LANCET, 2007, 369 (9570) :1379-1390
[7]   Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change [J].
Bruynesteyn, K ;
Boers, M ;
Kostense, P ;
van der Linden, S ;
van der Heijde, D .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :179-182
[8]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[9]   Receiver operating characteristic studies and measurement errors [J].
Coffin, M ;
Sukhatme, S .
BIOMETRICS, 1997, 53 (03) :823-837
[10]   Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change [J].
de Vet, Henrica C. ;
Terwee, Caroline B. ;
Ostelo, Raymond W. ;
Beckerman, Heleen ;
Knol, Dirk L. ;
Bouter, Lex M. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)